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Case Report
Skeletal Muscle Metastases from Urothelial Cell Carcinoma
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Hematogenous metastasis to skeletal muscle from urothelial carcinoma is extremely 
rare and metastatic disease to skeletal muscle tends to be found in people with ad-
vanced-stage neoplasm. We report in this paper a case of left sartorius muscle meta-
stasis from urothelial cell carcinoma. A left nephroureterectomy with bladder cuff ex-
cision was performed and revealed a high-grade papillary transitional cell carcinoma 
(TCC) of the pelvis. And 6 month later, recurrent bladder cancer was found regular cys-
toscopy and then treated with transurethral resection of the bladder.  After 6 times re-
section of bladder, an invasion into the bladder muscle layer was found. We recom-
mended additional radical cystectomy to prevent the disease from advancing. However, 
the patient refused additional surgery. 6 month later, the patient complained of left 
thigh pain, so ultrasonography-guided biopsy of the nodular mass lesion in the left sar-
torius muscle was performed. The pathological analysis of the biopsy specimen revealed 
poorly differentiated metastatic urothelial carcinoma.
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FIG. 1. Retrograde pyelography (A) and 
abdominopelvic computed tomography 
(B) showing the mass at the left renal 
pelvis.
Hematogenous metastasis to skeletal muscle from ur-
othelial carcinoma is extremely rare. We report a case of 
left sartorius muscle metastasis from urothelial carcinoma.
CASE REPORT
A 45 year old man presented with gross hematuria over the  
past 1 month. Ten years ago, he had undergone akidney 
transplantationowing to chronic renal failure. His family 
had a negative history of the disease. The physical exami-
nation revealed no specific findings except for the scar from 
the transplant operation. His serum creatinine on pre-
sentation was 1.7 mg/dl and urine analysis showed ad-
equate red blood cells. There were no abnormal findings in 
the bladder during cystoscopy and he underwent an ab-
dominopelvic computed tomography (CT) scan and retro-
grade pyelography, which revealed a 1.0x1.0 cm sized mass 
at the lower pole of the left renal pelvis (Fig. 1). The abdomi-
nopelvic CT scan, as performed, did not reveal metastasis 
to other organs or lymph nodes but there was a left renal Korean J Urol 2012;53:63-66
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FIG. 2. Thigh MRI (A), whole-body bone 
scan (B), and PET-CT (C) showing a mass
at the left sartorius muscle mass.
pelvis mass. The bone scan did not reveal bone metastasis, 
and the chest X-ray did not reveal any particular findings. 
A left nephroureterectomy with bladder cuff excision was 
performed and the pathological analysis showed a 
high-grade papillary transitional cell carcinoma (TCC) of 
the pelvis. TNM staging was T2NOMO. Six months later, 
a regular follow-up cystoscopy confirmed four tiny papil-
lary masses on the left lateral wall. Thus, he underwent 
transurethral resection of the bladder. Pathological tests 
showed a high-grade TCC, and the TMN staging was 
T1NOMO; Mytomycin-C instillation therapy was perfor-
med. The patient was under close follow-up. Clinical and 
radiological evaluations were done every 3 months in the 
first year. However, the bladder cancer recurred, and tran-
surethral resection of the bladder tumor was performed six 
times in the next 5 years. The pathological analysis of the 
resected bladder mass revealed high-grade TCC. An in-
vasion into the bladder muscle layer was found, and the 
TNM staging was T2N0M0. We recommended additional 
radical cystectomy to prevent the disease from advancing. 
However, the patient refused additional surgery because 
of his anxiety over losing a functional organ. He came in 
for dialysis owing to decreased renal function. 
On the sixth month after the sixth transurethral re-
section of the bladder, a regular follow-up abdominopelvic 
CT revealed an enlarged lymph node near the right iliac 
vessel and multiple paraaortic and aortocaval lymphaden-
opathy with aggravated bladder wall thickening. In addi-
tion, the patient complained of left thigh pain; thus, mag-
netic resonance imaging (MRI) of the thigh was performed. 
The MRI showed a 3.1x6.5 cm sized oval-shaped T1 slightly 
high and T2 heterogenous high-signal intensity lesion in 
the mid portion of the sartorius muscle (Fig. 2). The lesion 
showed strong enhancement after contrast injection, 
which suggested intramuscular metastasis. 
Ultrasonography-guided biopsy of the nodular mass le-
sion in the left sartorius muscle was performed (Fig. 3). The 
pathological analysis of the biopsy specimen revealed poor-
ly differentiated metastatic urothelial carcinoma (Fig. 4). 
Chest CT and abdominopelvic CT showed lung, bone, and 
lymph node metastasis. Radiation therapy to the left meta-
static skeletal muscle lesion and chemotherapy to the 
metastatic bladder cancer were performed.
DISCUSSION
Although skeletal muscle represents approximately 50% 
of the total body mass and receives a large portion of total 
cardiac output, hematogenous metastatic disease to the 
skeletal muscle is extremely rare. Several factors have 
been postulated to contribute to the resistance of skeletal 
muscle to metastatic disease. These factors include muscle 
motion and mechanical tumor destruction, inhospitable 
muscle pH, and the muscle’s ability to remove tumor-pro-
duced lactic acid that induces tumor neovascularity in oth-
er tissues [1]. Despite these defensive factors, metastases Korean J Urol 2012;53:63-66
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FIG. 4. The pathology of the left sartorius muscle biopsy specimen and bladder mass. (A) The needle-biopsied skeletal muscle showed 
metastatic tumor cells (H&E, x40).Irregular clusters of poorly differentiated tumor cells infiltrated with desmoplastic are shown. (B) 
Reaction within the skeletal muscle fiber (H&E, x100). (C) The tumor cells were polygonal or ovoid shaped and had abundant 
cytoplasm, irregular hyperchromatic nuclei, and occasional atypical mitoses (H&E, x400). (D) Transurethral resection of the urinary 
bladder revealed infiltrative urothelial carcinoma, showing similar cytologic features with the tumor cells in the skeletal muscle 
(H&E, x200).
FIG. 3. Ultrasonography-guided biopsy of the left sartorius muscle consistent with metastatic urothelial carcinoma.
to skeletal muscle have been reported from pancreatic, re-
nal, colonic, pulmonary, gastric, and ovarian primary 
malignancies. The malignant tumor to muscle metastasis 
per se isevidence of systemic spread, and it is a worse prog-
nosis than a metastasis to any other organ. 
Metastatic disease to skeletal muscle tends to be found 
in people with advanced-stage neoplasms. The largest 
muscles, such as the erector spinae, psoas, and gluteals, are 
the most common sites of metastatic involvement. 
The overall prevalence of skeletal muscle metastases in 
oncologic patients is not well reported. Subclinical meta-
stases to skeletal muscle may indeed be more common than 
is generally thought. One large autopsy study of 5,298 peo-
ple who died of malignancies found that 6% (298) involved Korean J Urol 2012;53:63-66
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the anterior chest wall or abdominal wall musculature and 
that 13% (666) involved the diaphragm [2]. Many of these 
lesions were microscopic and unlikely to be detected by any 
imaging technique. 
In this case, the patient complained of muscular pain, 
which is compatible with studies showing that most lesions 
are painful. Skeletal muscle metastasis may be an in-
cidental finding on CT of the chest or abdomen because 
most of the lesions identified were neither painful nor 
palpable.
The general CT findings of skeletal muscle metastasis 
show an increase in ring-shaped enhancement with central 
hypoattenuation, and MRI findings, although not specific, 
show low to intermediate signal intensity in the T1-weighted 
image and uniform high-signal intensity in the T2-weighted 
image. In this case, MRI showed a 3.1x6.5 cm sized 
oval-shaped T1 slightly high and T2 heterogenous high-sig-
nal intensity lesion in the sartorius muscle and strong en-
hancement after contrast injection, which suggested intra-
muscular metastasis. Biopsy can provide the appropriate 
diagnosis.
Methods for skeletal muscle metastases are still 
controversial. Ekici et al. [3] reported that if painful muscle 
metastasis is present, en bloc excision has good effects. 
Also, Pop et al reported that although not statistically sig-
nificant, there was a slight difference in survival rates 
among patients who underwent radiotherapy or chemo-
therapy compared with those who underwent different sur-
geries [4]. However, Klune et al. [5] reported that surgical 
treatment was selectively possible only in patients meet-
ing various conditions and recommended radiotherapy or 
chemotherapy. 
Regarding bladder tumor metastasis to skeletal muscle, 
Nabi et al. [6] reported that the mean survival rate after 
receiving chemotherapy was 8 months, but because such 
cases are rare, specific details are not known. Di Giorgio 
et al. [7] reported that in the case of lung cancer metastasis 
to skeletal muscle, the survival rate is considerably re-
duced compared with the absence of metastasis, and in the 
case of three patients, the survival rate was not good at 3, 
6, and 30 months. 
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